The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: A comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP)

J. D. Hainsworth, H. W. Jones, L. S. Burnett, D. H. Johnson, F. A. Greco

Int Med - Chairman's Office
Internal Medicine

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: A comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP)'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: A comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP)

Fingerprint

Medicine & Life Sciences